CClinicalTrials.gg
RecruitingNCT05492422Updated May 7, 2026

Central Executive Training and Parent Training for ADHD

An interventional study of Central Executive Training (CET) and Behavioral Parent Training (BPT) in ADHD, sponsored by Florida State University. Recruiting at 1 site in United States. Open to participants aged 8 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Florida State University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2022; still recruiting 4 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
8 Years to 12 Years
Sex
All
01

Study summary

The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities. BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors. Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.

02

Conditions studied

03

In context

Attention Deficit Disorder with Hyperactivity

1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.

This study's planned enrollment of 200 is above the median of 72 across 1,207 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and
  2. parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants).

All DSM-5 ADHD presentations will be eligible.

Exclusion criteria

Exclusion:

  1. gross neurological, sensory, or motor impairment;
  2. history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use);
  3. intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score \<70;
  4. conditions requiring acute intervention, e.g., active suicidality; and
  5. non-English speaking child or parent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    CET-then-BPT

    Families receive CET in Phase 1 followed by BPT in Phase 2

    Device: Central Executive Training (CET) · Behavioral: Behavioral Parent Training (BPT)

  • Experimental
    BPT-then-CET

    Families receive BPT in Phase 1 followed by CET in Phase 2

    Device: Central Executive Training (CET) · Behavioral: Behavioral Parent Training (BPT)

  • Experimental
    Waitlist then CET+BPT

    Families do not receive either intervention in Phase 1 and then receive both CET and BPT concurrently in Phase 2

    Device: Central Executive Training (CET) · Behavioral: Behavioral Parent Training (BPT)

  • Experimental
    CET+BPT then 'waitlist' (follow-up)

    Families receive CET and BPT concurrently in Phase 1, and then are followed in Phase 2 with not additional intervention

    Device: Central Executive Training (CET) · Behavioral: Behavioral Parent Training (BPT)

Interventions

  • DeviceCentral Executive Training (CET)

    Central Executive Training (CET)

  • BehavioralBehavioral Parent Training (BPT)

    Behavioral Parent Training (BPT)

06

What researchers measure

Primary outcomes

  1. Rapport visuospatial/phonological working memory test

    Time frame: Administered during a 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

  2. Alabama parenting scale

    Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

  3. Parenting sense of competence scale

    Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

  4. Parent stress index

    Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

Secondary outcomes

  1. Behavior Assessment System for Children

    Time frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

  2. ADHD Rating Scale

    Time frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

  3. ODD symptoms (DSM-based checklist)

    Time frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

Other outcomes

  1. Academic performance rating scale

    Time frame: Teacher questionnaire requiring approximately 15 minutes to complete, mailed to teacher within 2 weeks of last intervention session

  2. Parent relationship questionnaire

    Time frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session

  3. Dyadic parent-child interaction coding system (DPICS)

    Time frame: Structured parent-child interaction conducted during the post-treatment testing session within 2 weeks of final intervention session

07

Study locations

1 of 1 sites recruiting
  • Florida State University
    Tallahassee, Florida 32306, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05492422
Lead sponsor
Florida State University
Responsible party
Michael J. Kofler (Associate Professor, Florida State University) — Principal investigator
First posted
Aug 8, 2022
Start date
Oct 3, 2022
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
May 7, 2026

Study contacts

Children's Learning Clinic
Contact
clc@psy.fsu.edu
8506457423

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion